HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma

• Chen Shen,
• Mei Li,
• Yujuan Duan,
• Yujuan Duan,
• Xin Jiang,
• Xiaoming Hou,
• Fulai Xue,
• Yinan Zhang,
• Yao Luo

Affiliations

Chen Shen

Department of Laboratory Medicine, Medical Equipment Innovation Research Center/Medical Device Regulatory Research and Evaluation Center, West China Hospital, Sichuan University, Chengdu, China

Mei Li

Department of Laboratory Medicine, Medical Equipment Innovation Research Center/Medical Device Regulatory Research and Evaluation Center, West China Hospital, Sichuan University, Chengdu, China

Yujuan Duan

School of Chemical Science and Engineering, Tongji University, Shanghai, China

Yujuan Duan

School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, China

Xin Jiang

Department of Laboratory Medicine, Medical Equipment Innovation Research Center/Medical Device Regulatory Research and Evaluation Center, West China Hospital, Sichuan University, Chengdu, China

Xiaoming Hou

Department of Laboratory Medicine, Medical Equipment Innovation Research Center/Medical Device Regulatory Research and Evaluation Center, West China Hospital, Sichuan University, Chengdu, China

Fulai Xue

Department of Laboratory Medicine, Medical Equipment Innovation Research Center/Medical Device Regulatory Research and Evaluation Center, West China Hospital, Sichuan University, Chengdu, China

Yinan Zhang

School of Chemical Science and Engineering, Tongji University, Shanghai, China

Yao Luo

Department of Laboratory Medicine, Medical Equipment Innovation Research Center/Medical Device Regulatory Research and Evaluation Center, West China Hospital, Sichuan University, Chengdu, China